What Blood Tests Do You Need on Ozempic?
Whether you're taking Ozempic, Wegovy, Mounjaro, or Zepbound — routine lab work is essential. Here's exactly what your doctor should be ordering, what those panels actually tell you, and what standard blood tests completely miss.
The Standard Lab Panels Your Doctor
Should Be Ordering
GLP-1 medications like Ozempic and Wegovy are powerful drugs that affect your liver, kidneys, thyroid, blood sugar, and cardiovascular system. Here are the five core panels every patient on semaglutide or tirzepatide should be getting regularly.
Comprehensive Metabolic Panel (CMP)
The CMP is your metabolic baseline. It checks 14 substances in your blood and is the single most important panel for anyone on GLP-1 therapy.
- ALT & AST — liver enzymes to catch drug-induced liver stress early
- BUN & Creatinine — kidney function, especially important with rapid weight loss
- Fasting Glucose — tracks glycemic response to medication
- Electrolytes — sodium, potassium, CO₂ balance during caloric restriction
Lipid Panel
GLP-1 drugs often improve lipid profiles dramatically — but monitoring is essential to quantify progress and adjust statin co-prescriptions if needed.
- LDL Cholesterol — primary cardiovascular risk marker
- HDL Cholesterol — protective lipoprotein, should rise with treatment
- Triglycerides — often the first lipid to improve on GLP-1 therapy
- Total Cholesterol — the big-picture lipid number
Thyroid Panel
GLP-1 receptor agonists carry an FDA boxed warning for thyroid C-cell tumors based on rodent studies. Thyroid monitoring isn't optional — it's required.
- TSH — the primary thyroid screening test
- Free T4 — measures active thyroid hormone levels
- Calcitonin — elevated levels can signal medullary thyroid carcinoma risk
Inflammatory Markers
GLP-1s have documented anti-inflammatory effects. Tracking inflammation markers helps quantify this benefit and can flag hidden issues like pancreatitis risk.
- hs-CRP — high-sensitivity C-reactive protein, a cardiovascular inflammation marker
- ESR — erythrocyte sedimentation rate, a general inflammation gauge
- Lipase & Amylase — pancreatic enzymes, critical for detecting early pancreatitis
Complete Blood Count (CBC)
The CBC is a general health screening that checks for anemia, infection, and blood disorders — all of which can be unmasked by rapid weight loss and caloric restriction.
- Hemoglobin & Hematocrit — catches anemia from nutritional deficiency
- WBC Count — immune function baseline while on therapy
- Platelet Count — overall hematologic health marker
HbA1c (Bonus)
Not technically part of the standard panels above, but your HbA1c (hemoglobin A1c) is the single best measure of long-term blood sugar control over 2–3 months.
- HbA1c — tracks average glucose over 2–3 months, the gold standard for diabetes management
- Fasting Insulin — reveals insulin resistance trends before glucose rises
What Standard Blood Tests
Completely Miss
Here's the problem with everything above: those panels are lagging indicators. They show you what already happened in your body — not what's happening right now.
Your ALT might look normal today, but your liver could already be under stress at the cellular level. Your thyroid panel might read "within range" while gene expression patterns are already shifting. By the time blood markers change, you're weeks — sometimes months — behind.
That's where the mRNA layer comes in. Gene expression testing measures your body's real-time biological activity — the messenger RNA (mRNA) your cells are producing right now. It's like the difference between reading yesterday's weather report and looking out the window.
Standard Blood Tests
- ✕ Show what happened weeks ago
- ✕ Miss early cellular stress signals
- ✕ Can't tell you if you're losing muscle or fat
- ✕ Binary "in range" vs. "out of range" results
mRNA Gene Expression
- ✓ Captures real-time metabolic shifts
- ✓ Detects liver, thyroid, and muscle stress early
- ✓ Distinguishes muscle loss from fat loss
- ✓ Quantitative fold-change data, not just "normal"
Semaglutide vs. Tirzepatide:
Different Drugs, Different Monitoring
Ozempic and Mounjaro aren't the same drug — and they don't need the same monitoring. Semaglutide targets GLP-1 receptors only. Tirzepatide hits both GLP-1 and GIP receptors, creating a different metabolic profile that demands different attention.
Semaglutide
Ozempic® · Wegovy® · Rybelsus®
Mechanism
GLP-1 receptor agonist only — mimics the incretin hormone GLP-1 to slow gastric emptying, reduce appetite, and improve insulin sensitivity.
Key Monitoring Focus
- Thyroid function — highest priority given the GLP-1 C-cell warning
- Pancreatic enzymes — pancreatitis is a known semaglutide risk
- Kidney function — dehydration from nausea can stress kidneys
- Lean mass preservation — mRNA markers can detect muscle wasting signals
Tirzepatide
Mounjaro® · Zepbound®
Mechanism
Dual GLP-1/GIP receptor agonist — activates both incretin pathways simultaneously, producing more aggressive insulin sensitization and greater weight loss in trials.
Key Monitoring Focus
- Insulin & glucose dynamics — dual mechanism creates deeper glycemic shifts
- Liver enzymes — more aggressive fat mobilization means more hepatic processing
- Lipid metabolism — GIP pathway influences fat storage and breakdown differently
- Body composition — greater weight loss demands closer muscle-loss surveillance
Both drug classes benefit enormously from mRNA monitoring, which detects cellular-level shifts that blood panels miss entirely. Whether you're on Ozempic or Mounjaro, the standard labs above are necessary — but they're not sufficient.
Monitoring Is More Than
a Single Blood Draw
Understanding what to test is step one. You also need to know when to test, which biomarkers matter most, and how mRNA fills the gaps that standard labs leave wide open.
When to Test
Baseline, 4-week, 12-week, and ongoing schedules — timed to your titration and milestones.
View Schedule12 Key Biomarkers
The complete biomarker deep dive — every gene expression target we track and why it matters.
Explore BiomarkersThe mRNA Layer
How gene expression testing fills the gaps between blood draws — catching problems weeks before labs do.
Learn More
Frequently Asked
Questions
What blood tests should I get on Ozempic?
At minimum, your doctor should order a Comprehensive Metabolic Panel (CMP) to check liver and kidney function, a Lipid Panel for cholesterol and triglycerides, a Thyroid Panel (TSH + Free T4) given the FDA's boxed warning on GLP-1 drugs and thyroid C-cell tumors, Inflammatory Markers like hs-CRP, and a Complete Blood Count (CBC). An HbA1c is also strongly recommended if you're taking Ozempic for diabetes. For deeper insight, mRNA gene expression testing can detect metabolic changes weeks before they appear on standard blood work.
How often should I get blood work on semaglutide?
Most providers recommend a baseline panel before starting medication, a follow-up at 4 weeks (or when you reach your first dose escalation), another at 12 weeks, and then every 3–6 months once you're on a stable dose. If you're also adding mRNA monitoring, those are typically aligned with your blood draws for a complete picture. See our testing schedule page for the full recommended timeline.
Do I need a thyroid test on GLP-1 medication?
Yes. All GLP-1 receptor agonists — including Ozempic, Wegovy, Mounjaro, and Zepbound — carry an FDA boxed warning about thyroid C-cell tumors observed in rodent studies. While the human risk is still being studied, thyroid monitoring is considered standard of care. Your panel should include TSH, Free T4, and ideally calcitonin (a marker for medullary thyroid carcinoma). Patients with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not take these medications.
What's the difference between monitoring for Ozempic vs. Mounjaro?
The core panels (CMP, lipids, thyroid, CBC) apply to both. The key difference is in emphasis. Ozempic (semaglutide) is a GLP-1-only drug, so thyroid and pancreatic monitoring are the top priorities. Mounjaro (tirzepatide) is a dual GLP-1/GIP agonist that tends to produce more aggressive weight loss and deeper glycemic shifts — so liver enzyme monitoring, insulin/glucose dynamics, and lean-mass preservation become proportionally more important. In both cases, mRNA monitoring adds the critical "early warning" layer that blood tests alone can't provide.
What is mRNA testing and how is it different from regular blood work?
Standard blood tests measure the end products of biological processes — protein levels, enzyme concentrations, cell counts. By the time these numbers change, the underlying cellular shift happened weeks or months ago. mRNA testing measures gene expression — the messenger RNA your cells are actively producing right now. This gives you a real-time view of metabolic activity: inflammation pathways turning on, muscle catabolism genes activating, liver stress responses ramping up. It's the difference between a smoke alarm and a fire report. Learn more on our mRNA layer page.
Don't Fly Blind on
GLP-1 Therapy
Whether you're on Ozempic, Wegovy, Mounjaro, or Zepbound — get the full picture with standard labs plus mRNA monitoring from One Health Labs.